OR23-03 Post-Operative Day One Morning Cortisol Value as a Biomarker to Predict the Recurrence of Cushing Disease

Tumor removal by transsphenoidal surgery (TSS) is the first line treatment for Cushing disease (CD). However, recurrence is relatively common. A one week post-operative (post-op) nadir cortisol has been used as a biomarker to predict recurrence(1). We identified 299 CD patients from our longitudinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fang, Catalino, Michael, Bi, W Linda, Dunn, Ian, Smith, Timothy, Guo, Yunlei, Kaiser, Ursula B, Laws, Edward Raymond, Min, Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207532/
http://dx.doi.org/10.1210/jendso/bvaa046.1046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207532/
http://dx.doi.org/10.1210/jendso/bvaa046.1046

Ejemplares similares